Showing 1 - 5 of 5
Policy makers and health care payers are concerned about the costs of treating terminal patients. This study was done to measure the costs of treating terminal patients during the final month of life in a sample of Belgian nursing homes from the health care payer perspective. Also, this study...
Persistent link: https://www.econbiz.de/10010993853
Although the identified evidence of the costs and potential benefits of homeopathy seemed promising, studies were highly heterogeneous and had several methodological weaknesses. It is therefore not possible to draw firm conclusions based on existing economic evaluations of homeopathy....
Persistent link: https://www.econbiz.de/10010993855
Persistent link: https://www.econbiz.de/10005184513
Persistent link: https://www.econbiz.de/10009149814
Persistent link: https://www.econbiz.de/10005391157